MediLexicon Logo
MediLexicon Logo
Abbreviations        Abbrev Definitions        Dictionary        ICD Codes        Equipment        Hospitals        Drugs        More..
  


Accolate

Company: AstraZeneca
Approval Status: Approved October 1996
Treatment for: asthma
Areas: Respiratory
Possible similar drugs: Accolate

| General Information | Clinical Results | Mechanism of Action | Additional Information |


General Information

Accolate (zafirlukast) has been approved for the preventative and chronic treatment of asthma in adults and children 12 years of age and older.


Clinical Results

Accolate has been studied in more than 4,000 people worldwide. In clinical trials in patients with mild to moderate asthma, Accolate was shown to improve lung function and reduce daytime and nighttime asthma symptoms.


Mechanism of Action

Accolate is the first leukotrine receptor antagonist, a new class of drugs, to receive FDA clearance. Accolate works by blocking the effect of leukotrines, natural substances in the body that can contribute to asthma symptoms.


Additional Information

More than 12 million Americans suffer from asthma, and worldwide more than 100 million people have this chronic lung disease.




< back to top

Accolate Drug Information

The Accolate drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.





MediLexicon International Ltd Logo

Privacy Policy   |    Disclaimer   |    Contact / Feedback

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2014 All rights reserved.